Literature DB >> 16530766

Lack of value of the Martius fibrofatty graft in obstetric fistula repair.

A Browning1.   

Abstract

OBJECTIVE: To ascertain if the Martius graft is of benefit to successful surgical outcome in obstetric fistula repair.
METHOD: A retrospective analysis of 440 consecutive obstetric fistula repairs performed by the author in the Addis Ababa Fistula Hospital, Ethiopia or the Barhirdar Hamlin Fistula Center, Ethiopia, with or without the Martius fibrofatty graft. These were further divided into 13 subgroups of vesicovaginal fistula and all groups compared against two outcomes; fistula closure and presence of residual urethral incontinence following repair. Results were statistically analyzed with the Fisher's exact or Chi-squared test.
RESULTS: There was no statistical difference between groups with regards to breakdown of repair but a higher rate of residual incontinence in 3 subgroups with the Martius graft.
CONCLUSION: The Martius graft can be safely omitted from obstetric fistula repair if the surgeon is experienced, and performs the same type of repair as used in this analysis.

Entities:  

Mesh:

Year:  2006        PMID: 16530766     DOI: 10.1016/j.ijgo.2006.01.003

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  13 in total

Review 1.  Factors influencing urinary fistula repair outcomes in developing countries: a systematic review.

Authors:  Vera Frajzyngier; Joseph Ruminjo; Mark A Barone
Journal:  Am J Obstet Gynecol       Date:  2012-02-20       Impact factor: 8.661

2.  Determinants of postoperative outcomes of female genital fistula repair surgery.

Authors:  Mark A Barone; Vera Frajzyngier; Joseph Ruminjo; Frank Asiimwe; Thierno Hamidou Barry; Abubakar Bello; Dantani Danladi; Sanda Oumarou Ganda; Sa'ad Idris; Maman Inoussa; Maura Lynch; Felicity Mussell; Dulal Chandra Podder
Journal:  Obstet Gynecol       Date:  2012-09       Impact factor: 7.661

3.  [Vesicovaginal fistula. Incidence, etiology and phenomenology in Germany].

Authors:  C Hampel; A Neisius; C Thomas; J W Thüroff; F Roos
Journal:  Urologe A       Date:  2015-03       Impact factor: 0.639

Review 4.  State of the Art for Treatment of Vesicovaginal Fistula.

Authors:  Rachel A Moses; E Ann Gormley
Journal:  Curr Urol Rep       Date:  2017-08       Impact factor: 3.092

5.  Obstetric fistula: the ECWA Evangel VVF Center surgical experience from Jos, Nigeria.

Authors:  Carolyn V Kirschner; Kathleen J Yost; Hongyan Du; Jonathan A Karshima; Steven D Arrowsmith; L Lewis Wall
Journal:  Int Urogynecol J       Date:  2010-08-11       Impact factor: 2.894

6.  Factors Influencing Post-Operative Short-Term Outcomes of Vesicovaginal Fistula Repairs in a Community Hospital in Liberia.

Authors:  Oxana Munoz; C Bryce Bowling; Kimberly A Gerten; Rebecca Taryor; Andy M Norman; Jeff M Szychowski; Holly E Richter
Journal:  Br J Med Surg Urol       Date:  2011-11

7.  Transperitoneal transvesical laparoscopic repair of vesicovaginal fistulae: experience of a tertiary care centre in northern India.

Authors:  Vishwajeet Singh; Rahul J Sinha; Seema Mehrotra; Dheeraj K Gupta; Smita Gupta
Journal:  Curr Urol       Date:  2013-10-30

8.  Prospective randomized comparison of repairing vesicovaginal fistula with or without the interposition flap: Result from a tertiary care Institute in Northern India.

Authors:  Vishwajeet Singh; Seema Mehrotra; Ankur Bansal; Asif Akhtar; Rahul Janak Sinha
Journal:  Turk J Urol       Date:  2019-09-01

9.  The uses and outcomes of the Martius fat pad in female urology.

Authors:  Sachin Malde; Marco Spilotros; Ailsa Wilson; Mahreen Pakzad; Rizwan Hamid; Jeremy Ockrim; P Julian Shah; Tamsin Greenwell
Journal:  World J Urol       Date:  2016-07-07       Impact factor: 4.226

10.  Factors influencing choice of surgical route of repair of genitourinary fistula, and the influence of route of repair on surgical outcomes: findings from a prospective cohort study.

Authors:  V Frajzyngier; J Ruminjo; F Asiimwe; T H Barry; A Bello; D Danladi; S O Ganda; S Idris; M Inoussa; M Lynch; F Mussell; D C Podder; M A Barone
Journal:  BJOG       Date:  2012-08-20       Impact factor: 6.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.